66
Participants
Start Date
November 30, 2023
Primary Completion Date
January 6, 2025
Study Completion Date
January 6, 2025
NAL ER
Oral tablets
Placebo
Oral tablets
McMaster University Medical Centre, Hamilton
Inspiration Research, Toronto
CIC Mauricie Inc., Trois-Rivières
Hull and East Yorkshire Hospitals NHS Trust - Castle Hill Hospital, Cottingham
Kings College Hospital NHS Foundation Trust, London
University Hospital of South Manchester NHS Foundation Trust (UHSM) - Wythenshawe Hospital, Manchester
Accellacare South London, Orpington
Accellacare North London, Northwood
Belfast City Hospital, Belfast
North Tyneside General Hospital - Northumbria Healthcare NHS Foundation Trust, North Shields
Accellacare Warwickshire, Coventry
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Accellacare Yorkshire, Shipley
Egin Research Ltd, High Wycombe
Lead Sponsor
Trevi Therapeutics
INDUSTRY